about
Recombinant prion protein induces a new transmissible prion disease in wild-type animals.Olfactory Receptors in Non-Chemosensory Organs: The Nervous System in Health and DiseaseMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineHealth professions and risk of sporadic Creutzfeldt-Jakob disease, 1965 to 2010Neuropathological criteria of anti-IgLON5-related tauopathy.Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion diseaseFatal prion disease in a mouse model of genetic E200K Creutzfeldt-Jakob diseaseEndonuclease G mediates α-synuclein cytotoxicity during Parkinson's diseaseRapidly progressive dementia with thalamic degeneration and peculiar cortical prion protein immunoreactivity, but absence of proteinase K resistant PrP: a new disease entity?Rationale for diagnosing human prion disease.The prion protein in human neurodegenerative disorders.The prion protein in human neuromuscular diseases.Cathepsin D SNP associated with increased risk of variant Creutzfeldt-Jakob disease.How a neuropsychiatric brain bank should be run: a consensus paper of Brainnet Europe II.Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.Novel approach for accurate tissue-based protein colocalization and proximity microscopy.Psoriasis, bulbar involvement, and diarrhea in late myoclonic epilepsy with ragged-red fibers-syndrome due to the m.8344A > G tRNA (Lys) mutation.FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.Peroxisomal alterations in Alzheimer's diseaseEndocannabinoids modulate cortical development by configuring Slit2/Robo1 signallingNomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degenerationDetection of disease-associated α-synuclein in the cerebrospinal fluid: a feasibility studyPrimary age-related tauopathy (PART): a common pathology associated with human agingPART, a distinct tauopathy, different from classical sporadic Alzheimer disease.Prevalence of mixed pathologies in the aging brainMultiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.A genome wide association study links glutamate receptor pathway to sporadic Creutzfeldt-Jakob disease risk.Contribution of neuropathology to the understanding of human prion disease.A new mechanism for transmissible prion diseasesNeuropeptide S- and Neuropeptide S receptor-expressing neuron populations in the human pons.Post-mortem assessment in vascular dementia: advances and aspirations.Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusionsSexually Dimorphic Expression of Reelin in the Brain of a Mouse Model of Alzheimer Disease.Stabilization of a prion strain of synthetic origin requires multiple serial passagesSerotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjectsA Fluorescent Oligothiophene-Bis-Triazine ligand interacts with PrP fibrils and detects SDS-resistant oligomers in human prion diseases.Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models.A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats.Clinical neuropathology practice news 3-2012: the "ABC" in AD-revised and updated guideline for the neuropathologic assessment of Alzheimer's disease.
P50
Q24645106-DFC793D9-289A-4067-994A-EE62D7849D8FQ26741605-341B057B-F73C-419D-81E2-1FEBC9C38C4EQ26768648-53A697E9-F775-45D8-B960-F81FE984420EQ26830085-DE77A405-3F28-4840-A879-7BB0271D6755Q27321730-946E463E-487C-4D4E-9AD3-769BA86FDC4EQ27348022-6DDFA723-F5D9-4582-A3DF-698DB5E04472Q27348644-851E4B0E-52CD-458E-8255-55A29379C9D9Q28300290-A3EFA23C-0409-407C-9EE7-FEEFE5E3A469Q30446918-84695A22-D383-495C-A5CD-A043CF17AE9BQ30936688-7967279B-EEB4-4A74-964F-7E2C3B8774F6Q31104544-B602A312-CA8E-4B0D-BB26-93A77A599789Q31120109-6F060A47-82DA-48BB-A16E-5C6A50B55FF1Q33329713-EC923837-17F2-4611-9B92-0DA8C241D6CFQ33449817-FCE274F4-79F3-462C-9F37-33FE4EB66018Q33451012-56CF2B01-746C-46B0-9891-9457FFDE5B07Q33753090-35F7A43C-A89C-44B8-A50A-9C6D85FF9510Q33896827-C5ED630B-7A5C-40B9-B0E8-D22AD09C3B46Q33898394-CCB1434F-029E-4287-91C3-6A6DDBFA9E71Q33905478-181AF694-82BB-4B28-BE76-94ED5685C906Q33948817-69841C0B-AC7C-4246-B441-6F93AF8ED66CQ34020227-984F00A1-5CEC-47B7-A3BD-6F29FECE0187Q34038343-FEFC260F-DEB9-49A3-A24F-149E3AE54AEFQ34118169-D5489172-94E3-4D08-A0B2-BA7E495B8C17Q34445021-49557EC7-3D62-4E47-B2B7-26F26CAC87CFQ34467464-04BA57A5-631D-47E1-A6E0-0C786BF7AB15Q34551519-1E39FC5A-62E8-4E1F-88D8-54F855C9EE0DQ34607681-1100DB95-D074-4A2F-83CD-4E14CEA468B5Q35546911-5FDBCE76-F77D-4965-8C96-0FF18319DED6Q35902204-1212104E-1365-4774-963D-7D1FA1B11998Q36011275-E5BAC53C-A742-44CD-8952-4EAA624612E8Q36098035-F3C212FD-D4B2-4731-A772-CD76D7668C14Q36124590-8FB4DBC1-CBE4-4635-9F6C-08B79D2556CFQ36173620-8D58835E-07DE-49EC-9416-051636B355DCQ36198743-3872B81D-4BE1-4360-BB73-A112CF6AFBDEQ36216322-E51DD5B4-1A23-4C36-8C17-F5A7D9E22411Q36491567-64FCD394-8312-48B6-9DF5-D4318CE14F83Q36503630-A9CF7F89-8C7A-4EF2-A5C5-22467E3D97D2Q36668200-B5EC30EC-5BAB-432E-989D-BEED5A42B2FEQ36801066-30DF738B-B935-40A9-A1C0-7F9D7940725CQ36801066-30E7749D-6DB9-4F6B-93D2-5213B5449F38
P50
description
hulumtues
@sq
neuroloog
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Gabor G Kovacs
@ast
Gabor G Kovacs
@en
Gabor G Kovacs
@es
Gabor G Kovacs
@nl
Gabor G Kovacs
@sl
type
label
Gabor G Kovacs
@ast
Gabor G Kovacs
@en
Gabor G Kovacs
@es
Gabor G Kovacs
@nl
Gabor G Kovacs
@sl
altLabel
Gabor G. Kovacs
@en
prefLabel
Gabor G Kovacs
@ast
Gabor G Kovacs
@en
Gabor G Kovacs
@es
Gabor G Kovacs
@nl
Gabor G Kovacs
@sl
P214
P227
P244
P1053
A-7468-2013
P21
P214
P227
1152846035
P244
n2014191024
P2798
P31
P3829
P4012
P496
0000-0003-3841-5511
P569
1969-01-01T00:00:00Z
P7859
lccn-n2014191024